RhIGF-1

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
156	レット症候群	2

156. レット症候群

臨床試験数 : 44 / 薬物数 : 61 - (DrugBank : 23) / 標的遺伝子数 : 57 - 標的パスウェイ数 : 83

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01777542 (ClinicalTrials.gov)	January 2013	23/1/2013	Treatment of Rett Syndrome With Recombinant Human IGF-1	Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Hu ...	Rett Syndrome	Drug: Recombinant Human Insulin Growth Factor 1 (rhIGF-1);Drug: Placebo	Boston Children's Hospital	International Rett Syndrome Foundation	Completed	2 Years	10 Years	Female	30	Phase 2	United States
2	NCT01253317 (ClinicalTrials.gov)	December 2010	2/12/2010	Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)	Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With IGF-1	Rett Syndrome	Drug: rhIGF-1	Boston Children’s Hospital	International Rett Syndrome Foundation;Autism Speaks	Completed	2 Years	12 Years	Female	12	Phase 1	United States

First Previous1Next Last